RocTool (XPAR:ALROC) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALROC RocTool XPAR:ALROC
30 GF Score
Price €1.39
GF Value €0.15
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is RocTool Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

XPAR:ALROC
30GF Score
RocTool XPAR:ALROC
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is RocTool (XPAR:ALROC) Overvalued in 2026?

Based on GuruFocus' analysis, RocTool stock appears to be overvalued. The current stock price of €1.39 is trading 826.7% above its estimated GF Value™ of €0.15. GuruFocus considers RocTool to be Significantly Overvalued.

Key valuation signals for XPAR:ALROC:

  • Dividends Received:
  • GF Value™: €0.15 vs. price of €1.39 (826.7% above fair value)
  • GF Score™: 30/100 with 6 warning signs

No single metric tells the full story. See the XPAR:ALROC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RocTool Business Description

Other Exchanges 4CP:Germany
Address BP 341, Modul R, 34 Allee du Lac d'Aiguebelette, Le Bourget du Lac, FRA, 73375
RocTool is engaged in the research, development and licensing of molding technologies. It offers licenses of its patents to companies in automotive and transportation, construction and medical equipment market.
30GF Score

Get the complete analysis for XPAR:ALROC

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.39
Price
€0.15
GF Value